GlobeNewswire by notified

Indberetning af transaktioner med aktier i Schouw & Co.

Del

I henhold til Europa-Parlamentets og Rådets forordning (EU) nr. 596/2014 indberettes og offentliggøres oplysninger til Finanstilsynet om transaktioner med værdipapirer i Aktieselskabet Schouw & Co. udført af personer med ledelsesansvar og personer med nær tilknytning til dem.

1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)Navn

Peter Kjær
2.Årsag til indberetningen
a)Stilling/titel

Direktør
b)Første indberetning/ændring

Første indberetning
3.Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)Navn

AKTIESELSKABET SCHOUW & CO.
b)LEI-kode213800V2R9WMMZASKK57

4.Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)Beskrivelse af det finansielle instrument, instrumenttypen
Identifikationskode



Aktier
DK0010253921
b)Transaktionens art

Salg af aktier i forbindelse med udnyttelse af aktiebaseret incitamentsprogram
c)Pris(er) og mængde(r)Pris(er)Mængde(r)
DKK 608,50124 stk.
DKK 607,001.748 stk.
DKK 606,502.614 stk.
DKK 606,0078 stk.
DKK 605,00809 stk.
DKK 604,50238 stk.
DKK 604,00876 stk.
DKK 603,50126 stk.
DKK 603,00203 stk.
DKK 602,50200 stk.
DKK 602,001.759 stk.
DKK 601,001.663 stk.
DKK 600,5014 stk.
DKK 600,004.548 stk.
d)Aggregerede oplysninger
  • Aggregeret mængde
  • Pris


15.000 stk. aktier
DKK 9.046.107,00
e)Dato for transaktionen

7. marts 2023
f)Sted for transaktionen

Nasdaq Copenhagen, Cboe Europe Equities, Aquis Exchange Europe, Posit Mtf og Turquoise Europe


1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)Navn

Peter Kjær
2.Årsag til indberetningen
a)Stilling/titel

Direktør
b)Første indberetning/ændring

Første indberetning
3.Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)Navn

AKTIESELSKABET SCHOUW & CO.
b)LEI-kode213800V2R9WMMZASKK57

4.Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)Beskrivelse af det finansielle instrument, instrumenttypen
Identifikationskode



Aktier
DK0010253921
b)Transaktionens art

Udnyttelse af optioner
c)Pris(er) og mængde(r)Pris(er)Mængde(r)
DKK 512,0715.000 stk.
d)Aggregerede oplysninger
  • Aggregeret mængde
  • Pris


15.000 stk. aktier
DKK 7.681.050,00
e)Dato for transaktionen

9. marts 2023
f)Sted for transaktionen

Uden for markedsplads

Aktieselskabet Schouw & Co.

Vedhæftet fil

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates29.3.2024 05:24:27 CET | Press release

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB1,503 million during 2023. The revenue from pharmaceutical products increased by approximately 58% compared to 2022. The sales revenue of TUOYI® (toripalimab) was approximately RMB919 million, representing an increase of approximately 25% compared to the previous year.Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022. The decrease in R&D expenses was mainly due to the strategic management of R&D investments in certain early-stage pipelines, while optimizing resource all

Robex Announces Share Consolidation29.3.2024 00:30:00 CET | Press release

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES QUEBEC CITY, March 28, 2024 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) announces today that its Board of Directors has approved the implementation of the consolidation of the issued and outstanding common shares of the Company approved by its shareholders on June 29, 2023, on the basis of one (1) post-consolidation common share for ten (10) pre-consolidation common shares (the "Consolidation"), which will take effect on April 1st, 2024 (the "Effective Date"). As a result, the Company's consolidated shares are expected to commence trading on the TSX Venture Exchange a few days after the Effective Date. After the Consolidation, the shares will have a new CUSIP number and a new ISIN number. The Consolidation will reduce the number of issued and outstanding common shares of the Company from approximately 844,054,403 common shares to 84,405,449 common shares upon complet

Golar LNG Limited - Announcement of filing of Form 20-F Annual Report28.3.2024 22:47:27 CET | Press release

Golar LNG Limited announces that it has filed its Form 20-F for the year ended December 31, 2023 with the Securities and Exchange Commission in the U.S. Form 20-F can be downloaded from the link below, is available on our website (www.golarlng.com) and shareholders may receive a hard copy free of charge upon request. March 28, 2024 The Board of Directors Hamilton, Bermuda Enquiries: Golar Management Limited: + 44 207 063 7900 Stuart Buchanan This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment GLNG 2023 Annual Report Form 20-F

Magna Posts 2023 Annual Report28.3.2024 22:26:07 CET | Press release

AURORA, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG; NYSE: MGA) today announced that its 2023 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, Annual Information Form (AIF) and Form 40-F, are now available on the company’s website, www.magna.com. Magna has also filed these documents with the Canadian Securities Administrators (accessible through its website at www.sedarplus.ca) and the U.S. Securities and Exchange Commission (accessible through its website at www.sec.gov/edgar). Our 2024 Annual Meeting of Shareholders will be held on Thursday, May 9, 2024, commencing at 10:00 a.m. (Eastern Daylight Time). The meeting is being conducted as a virtual-only meeting accessible at www.virtualshareholdermeeting.com/MGA2024. Magna will provide a paper copy of its audited financial statements as contained in our 2023 Annual Report to Shareholders, free of charge, on request through our website, www.mag

Fortuna files Form 40-F, Annual Report28.3.2024 22:00:00 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that the Company has filed today its fiscal 2023 annual report on Form 40-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 40-F, which includes the Company’s fiscal 2023 annual audited financial statements, management’s discussion and analysis, and annual information form, is available on the Company’s website and on the SEC´s website. Printed copies of the annual financial statements are available free of charge to Fortuna shareholders upon written request. About Fortuna Silver Mines Inc. Fortuna Silver Mines Inc. is a Canadian precious metals mining company with five operating mines in Argentina, Burkina Faso, Côte d'Ivoire, Mexico, and Peru. Sustainability is integral to all our operations and relationships. We produce gold and silver and generate shared value over the long-term for our stakeholders through efficient production, environmental p

HiddenA line styled icon from Orion Icon Library.Eye